Posted on February 9, 2016 by Sitemaster
Today’s news contained items that run the spectrum from the clinical value of tomatoes and lycopene via the cardiovascular side effects of LHRH agonists and antagonists to the question of whether proton beam radiation therapy is really cost-effective. So here are the “news shorts” for the day: … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Prevention, Risk, Treatment | Tagged: agonist, antagonist, cost-effectiveness, LHRH, lycopene, proton beam, PSA density, side effect, testosterone, tomato | 3 Comments »
Posted on January 18, 2012 by Sitemaster
From a health economics point of view, prostate cancer costs a lot of money every year — because a lot of men get diagnosed and treated. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: active surveillance, cost, cost-effectiveness | 3 Comments »
Posted on September 16, 2008 by Sitemaster
Today’s news is focused on issues around prevention, screening, and active surveillance:
- The potential cost-effectiveness of widespread use of finasteride to prevent prostate cancer
- An update on data from the European Randomized Study of Screening for Prostate Cancer (ERSPC)
- The argument in favor of active surveillance as first-line management for men with low risk prostate cancer … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Prevention | Tagged: active, cost-effectiveness, finasteride. prevention, screening, surveillance | Leave a comment »
